bf/NASDAQ:MRKR_icon.jpeg

COM:MARKERTHERAPEUTICS

Marker Therapeutics

  • Stock

USD

Last Close

2.97

22/11 21:00

Market Cap

44.42M

Beta: -

Volume Today

11.73K

Avg: -

Description

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-speci...Show More

peer of

competitor of